Our digital cognitive
screening unlocks
timely access to care
meaningful intervention
more good years together
timely access to care
Lorem ipsum
Screen with confidence in a fraction of the time
Velit aliquet sagittis id consectetur purus ut faucibus.

PAYERS
Better ROI starts with better screening
Go from underdiagnosis to early diagnosis—and improved outcomes

Sed viverra
Outperforms the "gold standard"
FDA-registered device with groundbreaking sensitivity and specificity
Culturally agnostic
Designed with inclusive symbols and translated into multiple languages
Underdiagnosis is a costly problem
*in moderate to severe stages of Alzheimer's disease
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
Almost 60% of those with probable dementia are undiagnosed
*in moderate to severe stages of Alzheimer's disease
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
Identify who needs more care
*in moderate to severe stages of Alzheimer's disease
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
60% of PCPs say they don’t have enough time to screen
*in moderate to severe stages of Alzheimer's disease
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
$7.9 Trillion would be saved by early diagnosis
*in moderate to severe stages of Alzheimer's disease
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.
SOURCES: Aliquam ultrices sagittis orci a scelerisque purus. Venenatis cras sed felis eget.